Stay updated on Viatris Press Releases
Sign up to get notified when there's something new on the Viatris Press Releases page.

Latest updates to the Viatris Press Releases page
- Check2 days agoChange DetectedThe press releases page no longer displays the Keywords, Year, and Category filter controls, removing quick filtering by topic and date. This reduces the ability to refine the list to specific releases.SummaryDifference0.8%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded major corporate news (acquisition and exclusive rights) and investor conference participation; removed detailed phase 3 trial update and positive topline results. Overall page now emphasizes strategic business actions over past trial updates.SummaryDifference100%

- Check23 days agoChange DetectedThe page shifts from highlighting an upcoming financial results announcement to highlighting an employer award (Forbes Best Employers) for Viatris.SummaryDifference25%

- Check30 days agoChange DetectedUpdated page now highlights an upcoming November 6, 2025 financial-results announcement and removes a prior Phase 3 trial top-line result press release.SummaryDifference26%

- Check73 days agoChange DetectedViatris has appointed Andrew Enrietti as the Chief Administrative and Transformation Officer, marking a significant leadership change. The previous announcement regarding Viatris's participation in upcoming investor conferences has been removed.SummaryDifference15%

- Check80 days agoChange DetectedThe web page now includes an announcement regarding the approval of the first generic Iron Sucrose Injection by Viatris in the U.S., while a previous report on Viatris's first quarter results and outlook for 2025 has been removed.SummaryDifference19%

Stay in the know with updates to Viatris Press Releases
Enter your email address, and we'll notify you when there's something new on the Viatris Press Releases page.